Condition · 1 treatment path
Chronic Myeloid Leukemia (CML)
Chronic myeloid leukaemia is a blood cancer caused by the BCR-ABL gene change, known as the Philadelphia chromosome. It is usually found in its slow-growing chronic phase in adults.
Send your imaging + plan. Board-reviewed opinion in 5–10 working days.
- Treatment paths
- 1Treatment paths
- Specialties
- 1Specialties
- Typical severity
- SevereTypical severity
About chronic myeloid leukemia (cml)
What to know
Many people have no symptoms and are found through a routine blood count showing a high white cell count. Others have tiredness, night sweats, weight loss or an enlarged spleen. Diagnosis is confirmed by blood and bone marrow tests for BCR-ABL. If untreated, it can move to accelerated and blast phases.
Treatment with daily tyrosine kinase inhibitor tablets, such as imatinib, dasatinib or nilotinib, controls the disease in most people, with regular blood monitoring of BCR-ABL levels. A stem cell transplant is reserved for those whose disease resists several drugs or has progressed to an advanced phase. Treatment abroad is mainly considered for transplant, which needs a specialist centre and a matched donor.
Pre-flight workup
Tests to have already done
- Blood count with differential, and bone marrow biopsy report with cytogenetics showing the Philadelphia chromosome.
- BCR-ABL1 quantitative PCR result on the international scale, with the date, as the baseline for monitoring.
- Disease phase (chronic, accelerated or blast) and risk score, such as Sokal or ELTS, if calculated.
- Medicines you are taking now, with doses and any side effects, plus heart assessment (ECG) and liver and kidney function.
- Hepatitis B status, and cholesterol, glucose and lung or vascular history, which influence drug choice.
Second opinion
When to get a second look
- You have been diagnosed in accelerated or blast phase and need a specialist leukaemia centre's plan.
- Your BCR-ABL level is not falling as expected, or you have stopped responding to your tablet.
- You are considering stopping treatment or planning pregnancy and want specialist advice first.
Talking to your doctor
Questions to ask
- Which phase and risk score do I have, and which tyrosine kinase inhibitor is best for me?
- How often will BCR-ABL be tested, and what response is expected at three, six and twelve months?
- What are the side effects of my drug, and how will they be managed?
- Could I ever safely stop treatment, and under what conditions?
- How do I keep a reliable supply of my tablet if I travel?
Outlook
Realistic prognosis
With modern tyrosine kinase inhibitors, most people with chronic-phase CML reach deep responses and have a near-normal life expectancy, provided they take the tablets reliably and are monitored regularly. Some can later try treatment-free remission under specialist supervision. Outlook is worse in accelerated or blast phase, or when resistance develops, where other drugs or stem cell transplant may be needed.
01 · Specialties
Specialties that treat Chronic
Diagnostic workup
Before you pick a hospital, get the workup right
Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.
- Confirm the diagnosis on imaging or labs
For chronic myeloid leukemia (cml), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
- See a oncology specialist locally first
An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
- Send us the file for a free second opinion
Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
- Pick a path with timeline + cost in writing
Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.
03 · Treatment paths
Treatment options
Where to be treated
Chronic Myeloid Leukemia (CML) treatment by destination
04 · FAQ
Common questions about chronic myeloid leukemia (cml)
Is CML curable?
Most chronic-phase patients achieve long-term control with daily tablets and live near-normal lives. True cure is uncommon, though some people can stop treatment under specialist monitoring after a sustained deep response.
Will I need a bone marrow transplant?
Most do not. Transplant is considered mainly for advanced phases, or when the leukaemia becomes resistant to several tablets.
Can I stop taking the tablet if I feel well?
You should not stop on your own. Stopping without supervision can allow the leukaemia to return quickly, and any decision to stop is made by your haematologist.
Can I travel with CML?
Yes, with enough tablets for the trip plus extra, a letter from your doctor, and a plan for monitoring tests while away.
Clinical context
Working up chronic myeloid leukemia (cml) properly
A condition like chronic myeloid leukemia (cml) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.
Diagnostic workup, in sequence
- First-line clinical assessment
History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.
- Standard imaging + labs
Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.
- Specialist diagnostic workup
Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.
- Multidisciplinary review (where indicated)
Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.
When to escalate urgently
- Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
- Loss of consciousness, severe persistent vomiting, or any focal neurological event.
- Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
- If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.
Before you book international travel
- Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
- Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
- Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
- Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
- Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Methodology and editorial standards
This chronic myeloid leukemia (cml) overview is written by the editorial team from published Oncology sources and lists 1 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.
- Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
- Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
- Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
- Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
- Independence. Hospitals cannot pay to change their position on our pages.
Chronic Myeloid Leukemia (CML)
Continue evaluating chronic myeloid leukemia (cml) care
Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating chronic myeloid leukemia (cml).
- Surgeons Doctors treating Chronic Myeloid Leukemia (CML) Volume-ranked specialists across all relevant specialties.
- Specialty Oncology hub Programs, surgeons, hospitals across oncology.
- Procedure Allogeneic Bone Marrow Transplant First-line treatment with success rates, recovery, hospital pricing.
- Browse All 79 conditions Map condition → specialty → first-line treatment.
- Browse 9 destination countries Cost-of-care profiles, hospital programs, visa playbooks.
- Compare Hospital comparison Side-by-side accreditations, ratings, beds, and pricing.
- Compare Doctor comparison Surgeons compared on volume, fees, languages, video-consult availability.
- Tool Match-me triage Three questions, get a specialty + destination + 3-hospital shortlist.
- Tool Cost calculator Hospital-reported pricing across procedures × destinations.
- Action Free second opinion Independent panel review of your case in 48 hours — no charge.
Next step · Chronic Myeloid Leukemia (CML)
Free second opinion on your Chronic case.
Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.